SUBSCRIBE
SUBSCRIBE

Travere Therapeutics

NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Retrophin Booted CEO For Multiple Stock Violations: Report
October 3, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Retrophin, Inc., Gilead Sciences, Inc., And Our Healthcare Values
September 15, 2014
 · 
1 min read
Load More
JOBS
IN THE PRESS
Business
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
February 8, 2024
 · 
1 min read
Biotech Beach
Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
February 1, 2024
 · 
1 min read
Biotech Beach
Travere Therapeutics Announces Licensing Agreement with Renalys Pharma to Develop and Commercialize Sparsentan in Japan, South Korea, Taiwan, and Southeast Asian Nations
January 25, 2024
 · 
14 min read
Biotech Beach
Travere Therapeutics Provides Corporate Update and 2024 Outlook
January 8, 2024
 · 
15 min read
Biotech Beach
Travere Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 2, 2024
 · 
1 min read
Drug Development
Travere Therapeutics Initiates Pivotal Phase 3 Clinical Trial of Pegtibatinase for the Treatment of Classical Homocystinuria (HCU)
December 14, 2023
 · 
9 min read
Biotech Beach
Travere Completes Successful pre-NDA Meeting for FILSPARI in IgAN; Provides Regulatory Updates for both IgAN and FSGS
December 4, 2023
 · 
20 min read
Biotech Beach
Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
 · 
1 min read
Business
Travere Therapeutics Reports Third Quarter 2023 Financial Results
November 7, 2023
 · 
27 min read
Biotech Beach
Travere Therapeutics Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM Respectively and Presented at the American Society of Nephrology (ASN) Kidney Week 2023
November 3, 2023
 · 
21 min read
Load More